The University of Texas MD Anderson Cancer Center today was awarded $30 million to support research, core facilities, recruitment and prevention efforts from the Cancer Prevention and Research Institute of Texas (CPRIT). An additional $19.9 million was awarded to a company co-founded by MD Anderson to support the development of a novel targeted therapy to treat neurological conditions caused by chemotherapy. In total, MD Anderson and...
The University of Texas MD Anderson Cancer Center and Accelerator Life Science Partners, a leading life science investment and management...